Is it worth expending energy to convert biliverdin (cas 114-25-0) into bilirubin?

Add time:08/22/2019    Source:sciencedirect.com

Bilirubin (BR) is generated by the reduction of biliverdin (cas 114-25-0) (BV), a metabolite that results from the catalytic degradation of heme by the isoforms of heme oxygenase (HO). BV is nontoxic and water-soluble but BR is potentially toxic and lipophilic. Therefore, a further metabolic step is required for BR before excretion is possible. The reductive conversion of BV to BR costs energy and is evolutionarily conserved in human physiology. There must be a compelling reason for this apparently nonsensical evolutionary conservation. In addition to the differences between BR and BV—such as water solubility, antioxidant activity, and participation as a receptor ligand—in the present study, we focused on the chemistry of the two metabolites with regard to an electrophilic functional group called a Michael reaction acceptor (MRA). Our data reveal that the BR reacts with thiol compounds forming adducts, whereas no reaction occurs with BV. Furthermore, the binding of biotin-tagged BR to Kelch-like ECH-associated protein 1 (KEAP1)—a biological electrophile sensor—was prevented by pretreatment with BR or a thiol compound, but was not by pretreatment with BV. In cells, BR could bind to KEAP1 to release and activate nuclear factor-erythroid 2 (NF-E2) p45-related factor 2, a cytoprotective transcription factor, leading to the induction of HO-1. These findings may provide a physiological rationale for the energy-consuming conversion of BV to BR.

We also recommend Trading Suppliers and Manufacturers of biliverdin (cas 114-25-0). Pls Click Website Link as below: cas 114-25-0 suppliers

Prev:Research paperModeling structure and excitation of biliverdin (cas 114-25-0)-binding domains in infrared fluorescent proteins
Next:l-Histidine, arachidonic acid, biliverdin (cas 114-25-0), and l-cysteine-glutathione disulfide as potential biomarkers for cured pulmonary tuberculosis)